Dianthus Therapeutics
DNTH
DNTH
30 hedge funds and large institutions have $136M invested in Dianthus Therapeutics in 2023 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 9 increasing their positions, 10 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
61% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 23
Holders
30
Holding in Top 10
1
Calls
$4K
Puts
–
Top Buyers
| 1 | +$29M | |
| 2 | +$26.4M | |
| 3 | +$20.1M | |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$16.6M |
| 5 |
VA
VR Adviser
New York
|
+$12.7M |
Top Sellers
| 1 | -$1.43M | |
| 2 | -$287K | |
| 3 | -$252K | |
| 4 |
Two Sigma Advisers
New York
|
-$134K |
| 5 |
HCA
Harbor Capital Advisors
Chicago,
Illinois
|
-$127K |